COVID-19 Funding opportunities 

  • As a reminder, conducting on-campus research requires approval during the lock down period.  Click here for more information.
  • For COVID-19 proposal development questions and support, please contact Katie Pizer, BSD Executive Director for Research Administration:  kpizer@bsd.uchicago.edu    
  • To collaborate with other scientists across UChicago and the National Labs who are working on COVID-related research, complete a COVID Faculty Intake Form
  • The BSD Funding Opportunities website lists additional agency, UChicago, and BSD notices and guidelines. 

Last updated: September 17, 2020

AgencyProgramDeadline
Schmidt FuturesFutures Forum on Learning: Tools Competition9/18/2020
NIH, NIA, NCI, RM, NCATS, NHLBI, NIDCR, NIDA, NHGRIEmergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed)9/18/2020
NIH, NIAAA, NIAMS, NICHD, NIBIB, NIMHD, NLM, NCATS, NHLBI, NIDCREmergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (Fast-Track STTR Clinical Trial Not Allowed)9/18/2020
NIH, NIAAA, NIA, NIAMS, NICHD, NIBIB, NIMHD, NLM, NCATS, NHLBI, NIDCREmergency Awards RADx-RAD: Screening for COVID-19 by Electronic-Nose Technology (SCENT) (U18 Clinical Trial Not Allowed)9/18/2020
NIH, NIAAA, NIA, NCCIH, NIDCD, NIDDK, NIEHS, NIGMS, NICHD, NIMHD, NLM, NINR, NCATS, OBSSR, NHLBI, NIDCR, NIDAEmergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (R44 Clinical Trial Not Allowed)9/18/2020
NIH, NIOSHNIOSH Centers of Excellence for Total Worker Health® (U19) - LIMITED9/25/2020;
Various
CEPIAccelerating vaccine development and global manufacturing capacity to stop the COVID-19 pandemic9/28/2020
FDAFDA COVID-19 Diagnostic Test Fellowship9/30/2020
NIH, NIAAA, NIDDK, NIGMS, NIMHD, NLM, NINR, OBSSR, NIDCR, NIDAEmergency Awards: RADx-RAD Multimodal COVID-19 surveillance methods for high risk clustered populations (R01 Clinical Trial Optional)9/30/2020
NIH, NIAAA, NIA, NCCIH, NIDCD, NIDDK, NIEHS, NIGMS, NICHD, NIMHD, NLM, NINR, NCATS, OBSSR, NHLBI, NIDCR, NIDAEmergency Awards: RADx-rad Data Coordination Center (DCC) (U24 Clinical Trial Not Allowed)9/30/2020
NIH, RMODNIH Directors Emergency Transformative Research Awards (R01 Clinical Trial Optional)9/30/2020
NIH, FIC, NCATS, NHLBI, NIAID, NIAMS, NICHD, NIDA, NIMHDEmergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional)9/30/2020
NIH, NHLBI Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials10/05/2020
NIH Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19)10/06/2020
Fundación MAPFRE2020 Research Grants in Health Promotion10/30/2020
WorkSafeBCApplied Research to Address The Coronavirus (COVID-19) Emerging Public Health Emergency10/31/2020
Biomedical Advanced Research and Development Authority (BARDA) Applied Research to Address The Coronavirus (COVID-19) Emerging Public Health Emergency10/31/2020
NIH – NIANIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required)10/01/2020, 11/02/2020, 12/01/2020, 01/04/2021, 02/01/2021
Adira FoundationAdira's Fast-Track Grant Response: COVID-19
(Alzheimer’s, ALS, Huntington’s, multiple sclerosis, and Parkinson’s)
Continuous
Biomedical Advanced Research and Development Authority (BARDA) BARDA's Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency AnnouncementContinuous
Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) - includes COVID-19 areas of interestApplications accepted on a rolling basis

Deadline: 10/31/2020
Bloomberg PhilanthropiesCoronavirus Local Response InitiativeContinuous
CiscoPandemic/COVID19 Science, Technology and Social ImpactRolling
Department of Energy (DOE)Department of Energy (DOE) Invitation for COVID-19 scientific questions:Responses will be reviewed beginning 03/18/2020
Department of Defense (DoD)Request for Information for PPE in response to COVID-19Responses will be reviewed beginning 03/24/2020
Defense Logistics AgencyRequest for White Papers: COVID-19 Prototype PPE and Decontamination EquipmentRolling
Gilead Sciences, Inc./ Gilean Sciences Pty LtdInvestigator Sponsored Research (ISR) Continuous
GoogleCOVID-19 Related Research credits available from Google Cloud
Research involving the use of patient data, including de-identified data, cannot be considered for this opportunity. Please inform BSD Information Security of your use of Google Cloud resources by emailing: security@bsd.uchicago.edu
International AIDS SocietyCIPHER Grant ProgramApplications open 10/01/2020
KaggleCOVID-19 Open Research Dataset Challenge (CORD-19)Open
Merck KGaAResearch Grant for Pandemic PreparednessRolling
National Science Foundation (NSF)Rapid Response Research (RAPID) Funding Mechanism
National Science Foundation (NSF)Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19)Rapid Proposals; Check with program officers
National Science Foundation (NSF) NSF Rapid Release Funding MechanismRolling
NIH Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional)LOI due 10/05/2020
NIHNotice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel CoronavirusOpen through 04/16/2021
NIHNotice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health DisparitiesOpen through 05/01/2021
NIHResearch on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Basic Experimental Studies with Humans Required)03/17/2021
NIHResearch on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Clinical Trials Not Allowed)03/17/2021
NIHNotice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAAOpen through 04/16/2021
NIHEmergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional)See Emergency Notice of Special Interest by IC
NIH - NIDCDNotice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders09/08/2022
NIH - NIGMSNotice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2
2/6/2021
NIH - NCATSNotice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Needmultiple deadlines; see opportunity
NIH - NCATSNotice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)10/17/2020
NIH - NCATSNotice of Special Interest (NOSI): Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs11/11/2020
NIH - NCATS Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social SciencesOpen through 04/01/2021
NIH - NCATSEmergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel CoronavirusOpen through 01/26/2022
NIH - NIA and NIMHNotice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)05/01/2021
NIH - NIAID and NIAInvestigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)01/13/2021, 05/13/2021, 09/13/2021, 01/13/2022, 05/13/2022
NIH - NIAIDNIAID’s Multi-Pronged Response to the COVID-2019 Outbreak
02/06/2021
NIH - NIEHSNotice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)05/04/2021
NIH - NIBIB Notice of Special Interest (NOSI): Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)Open through 11/10/2020
NIH - NIBIBNotice of Special Interest (NOSI): Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)03/31/2021
NIH - NINDS, NIAAANotice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous SystemOpen Through 04/15/2021
NIH - NIDCRNotice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCR11/02/2020
NIH - NCATSNotice of Special Interest (NOSI): New Administrative Supplement Applications to UL1 and U24 CTSA Awards to Address COVID-19 Public Heath Need11/11/2020
NovartisNovartis US COVID-19 InitiativeContinuous
PCORIPhased Large Awards for Comparative Effectiveness Research – Cycle 3 2020 LOI due 09/29/2020; 01/12/2021
Robert Wood Johnson FoundationPioneering Ideas: Exploring the Future to Build a Culture of HealthContinuous
The COVID-19 High Performance Computing (HPC) ConsortiumThe COVID-19 High Performance Computing Consortium Continuous
UK-RAS NetworkMedical Robotics for Contagious Diseases Challenge 202009/30/2020
US ArmyArmy Applications Lab: Call for COVID-19 ProposalsContinuous
NIH, NIMHD, NCI, NIDA, NLM, ODP, OBSSR, NIMH, NIAMSNotice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health DisparitiesContinuous
NIH, NIAID Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed)Continuous
NIH, NIADNotice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2Continuous
NIH, NCATSNotice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath NeedVarious
Expires July 10, 2021
NIH, NCATSNotice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19)10/5/2020;
10/16/2020
NIH, NCATS, NCCIH, NCI, NHGRI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINR, NLM, ORWH, OSCEmergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)Various
NIH, NCI, NHGRI, NCCIH, NINDS, ORIP, NIMHD, NIA, NIDCR, NIAID, NIAMS, NIEHS, NCATS, NIDCD, NICHD, NIDDK, NHLBINotice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project7/12/2021
NIH, NIAID Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)7/01/2021
Department of StateCOVID-19 Private Sector Engagement & Partnership Fund5/28/2021
NIH, NIDA Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus3/31/2021
NIMH, NCCIH, SGMRO, ODP, NIDCD, OBSSR, NEI, NIDA, NIA, NIAAA, NICHD, NCATS, ORWH, NIDCR, NINR, NIMHDDigital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional)3/02/2021
NIH, NCATSNotice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus1/25/2021
NIH, NCATSUrgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required)1/23/2021
HHS Annual Estimates of Influenza Vaccine Effectiveness for Preventing Medically Attended Laboratory-Confirmed Influenza in the United States01/08/2021
NIH, NIMHD, NIAAA, NCCIH, NIDCR, NCATS, NIEHS, ORWH, NIDA, OBSSR, NIDCD, SGMRO, NICHD, ODP, NIMH, NHLBI, NIA, NEI, NIDDKNotice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations12/29/2020
NIH, NIDDKMechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional)12/16/2020
NIMHD, NIDCD, NIMH, ODP, NINR, NIA, SGMRO, NIDDK, NIEHS, NICHD, NCATS, ORWH, NIAAA, NCCIH, NIDA, NEI, NIDCRCommunity Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)12/01/2020
Russell Sage FoundationSocial, Political, Economic, and Psychological Consequences of the COVID-19 Pandemic11/04/2020; 11/11/2020